NEW YORK, March 5, 2026, 05:53 EST
- Amprius is targeting revenue of no less than $125 million in 2026, projecting a net loss below $8 million and adjusted EBITDA of $4 million or more.
- Fourth-quarter revenue hit $25.2 million. Gross margin landed at 24%, and adjusted EBITDA swung into positive territory for the first time.
- The company logged a $22.5 million impairment related to its Colorado site, leaving cash at $91.9 million at year-end.
Amprius Technologies shares jumped roughly 8% ahead of Thursday’s open after the company projected at least $125 million in revenue for 2026 and said it anticipates narrowing its net loss to under $8 million. The silicon-anode battery producer is also aiming for positive adjusted EBITDA — a metric excluding interest, taxes, and non-cash charges — following its first positive quarterly adjusted EBITDA in the fourth quarter.
Guidance like that tends to outweigh last quarter’s results for small battery developers. A lot of these firms are still working to show they can manufacture cells with acceptable margins—outside of controlled lab settings.
Amprius builds lithium-ion cells with silicon anodes, not the usual graphite. That push for higher energy density comes with some hit to cycle life, but the company’s targeting drones and aviation—markets willing to shell out for lighter batteries.
Amprius logged a GAAP loss for the quarter, weighed down by a $22.5 million impairment charge linked to its Colorado site—the company pulled the plug on that lease, opting instead for a “capital-light” approach using contract manufacturers. Management pointed to a bigger Defense Innovation Unit contract for NDAA-compliant drone batteries, which tick the right boxes for U.S. National Defense Authorization Act sourcing, and also noted a new selection by Nokia Drone Networks. CEO Tom Stepien pointed to “meaningful commercial progress” in 2025, while CFO Ricardo Rodriguez described 2026 as a “step function in growth and profitability.” Amprius Technologies, Inc.
Amprius Technologies, Inc. included its results release as an exhibit in a Form 8-K filing with the Securities and Exchange Commission.
Excluding the impairment, Amprius posted a quarterly loss of 1 cent per share, narrower than the 4-cent loss analysts had projected, per an Associated Press roundup of Zacks figures. Analysts were looking for revenue around $23.1 million, the same AP report noted.
Stepien and Rodriguez are set for investor meetings at the Cantor Global Technology Conference in New York, March 10-11, with another appearance at a Roth conference following later in the month, according to the company. CTO Ionel Stefan is also on the schedule to present at the International Battery Seminar in Orlando.
This update lands as next-generation battery players fight for the spotlight. Silicon-anode contender Enovix, along with solid-state hopefuls QuantumScape and Solid Power, are each touting batteries they say will outdo standard lithium-ion cells on energy density. Major cell manufacturers keep notching up small improvements, which tightens the margin for error among startups chasing breakthroughs.
Still, Amprius needs its partners to deliver the expected yields—and it’s counting on customers to move beyond pilot runs to bigger, ongoing orders. Missed quality marks, component sourcing holdups, or shaky demand could all threaten those 2026 targets.
Management takes questions and reviews the figures Thursday at 8:30 a.m. ET. Investors want details on how much of the 2026 revenue target is already secured—and what’s required to keep capex down.
